ANALYSIS OF PERIOPERATIVE CLINICAL FEATURES AND COMPLICATIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH BIOLOGIC AGENTS

被引：0
作者：
Ishii, K. [1 ]
Mochida, Y. [1 ]
Harigane, K. [1 ]
Yamada, Y. [1 ]
Mitsugi, N. [2 ]
Saito, T. [3 ]
机构：
[1] Yokohama City Univ, Med Ctr, Ctr Rheumat Dis, Yokohama, Kanagawa 232, Japan
[2] Yokohama City Univ, Med Ctr, Dept Orthopaed Surg, Yokohama, Kanagawa 232, Japan
[3] Yokohama Cty Univ, Dept Orthopaed Surg, Yokohama, Kanagawa, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.2027
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：173 / 174
页数：2
相关论文
共 50 条
  • [21] Analysis of perioperative clinical features and complications after orthopaedic surgery in rheumatoid arthritis patients treated with tocilizumab in a real-world setting: results from the multicentre TOcilizumab in Perioperative Period (TOPP) study
    Momohara, Shigeki
    Hashimoto, Jun
    Tsuboi, Hideki
    Miyahara, Hisaaki
    Nakagawa, Natsuko
    Kaneko, Atsushi
    Kondo, Naoki
    Matsuno, Hiroaki
    Wada, Takahiko
    Nonaka, Tohgo
    Kanbe, Katsuaki
    Takagi, Haruki
    Murasawa, Akira
    Matsubara, Tsukasa
    Suguro, Toru
    [J]. MODERN RHEUMATOLOGY, 2013, 23 (03) : 440 - 449
  • [22] DISCORDANCE OF CLINICAL REMISSION AND IMAGING REMISSION BY ULTRASONOGRAPHY IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH BIOLOGIC AGENTS
    Kondo, Y.
    Kaneko, Y.
    Saito, S.
    Ohta, Y.
    Sakata, K.
    Inoue, Y.
    Takahashi, C.
    Hiramoto, K.
    Inamo, J.
    Takeuchi, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 986 - 986
  • [23] SERIAL INTERFERON-GAMMA RELEASE ASSAYS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH BIOLOGIC AGENTS
    Huang, Y. J.
    Fang, Y. F.
    Chen, Y. F.
    Tsai, P. H.
    Kuo, C. F.
    Yu, K. H.
    Luo, S. F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 333 - 333
  • [24] Biologic agents in the treatment of rheumatoid arthritis
    Hasegawa, Hitoshi
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 67P - 67P
  • [25] Biologic agents for the treatment of rheumatoid arthritis
    Strand, V
    Keystone, E
    Breedveld, F
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1996, 22 (01) : 117 - &
  • [26] Perioperative management of patients with rheumatoid arthritis in the era of biologic response modifiers
    Rosandich, PA
    Kelley, JT
    Conn, DL
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2004, 16 (03) : 192 - 198
  • [27] INFLUENCE OF BIOLOGIC AGENTS ON POSTOPERATIVE INFECTION IN RHEUMATOID ARTHRITIS PATIENTS
    Tada, M.
    Koike, T.
    Inui, K.
    Sugioka, Y.
    Mamoto, K.
    Okano, T.
    Nakamura, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 389 - 389
  • [28] The Effect of Biologic Agents on Hemoglobin Levels of Patients with Rheumatoid Arthritis
    Lee, Hwajeong
    Choe, Jung-Yoon
    Kim, Seong-Kyu
    Park, Seonghoon
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [29] ASSESSMENT OF PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS ELIGIBLE FOR BIOLOGIC AGENTS
    Degli Esposti, L.
    Perrone, V
    Sangiorgi, D.
    Sinigaglia, L.
    [J]. VALUE IN HEALTH, 2019, 22 : S433 - S434
  • [30] The impact of biologic agents on cardiovascular risk factors in patients with rheumatoid arthritis: A meta analysis
    Jia, Xiaodong
    Yang, Zheming
    Li, Jiayin
    Mei, Zhu
    Jia, Lihui
    Yan, Chenghui
    [J]. PLOS ONE, 2024, 19 (08):
12345